Cervical cancer

Cervical cancer, which is caused in nearly 100% of cases by a sexually transmitted human papillomavirus infection, can be prevented through HPV vaccination and screening.

Our missions

  • Monitoring epidemiological trends in cervical cancer

  • Evaluating the national organized cervical cancer screening program

  • Monitoring vaccination coverage for human papillomavirus infections

The disease

A cancer caused by the sexually transmitted HPV virus

Each year, nearly 3,000 women develop cervical cancer, and 1,000 women die from it.

In the vast majority of cases, cervical cancer is caused by a persistent infection with a high-risk human papillomavirus (HPV), a very common infection...

Learn more

What We Do

Cervical cancer, which is caused by a persistent HPV infection in nearly 100% of cases, is preventable through HPV vaccination and screening.
In this context, Santé publique France’s efforts focus on epidemiological surveillance, evaluating the organized screening program, promoting HPV...

Learn more

Data

Incidence and mortality rates have been declining since the 1990s

In mainland France, cervical cancer is the 11th most common cancer among women.

  • An estimated 3,159 new cases are projected for 2023

  • Three-quarters of cases occur in women aged 25–64

  • The incidence rate (world-standardized) is...

Learn more

Publications

Here you will find the latest scientific publications related to the studies and research conducted by Santé publique France.

2 publications

In relation to

Human papillomavirus infections

thematic dossier

Human papillomavirus (HPV) infection is a sexually transmitted infection caused by the human papillomavirus (HPV). The infection is usually asymptomatic and clears up within a few months. In some...

Learn more